Navigation Links
MiMedx Announces Launch of AmnioFix™ Nerve Wrap
Date:5/4/2011

MARIETTA, Ga., May 4, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products and bioimplants processed from human amniotic membrane, announced today the launch of AmnioFix™ Nerve Wrap, the Company's latest biologic implant processed to offer surgical and healing options for nerve repair.

Produced from the MiMedx Group's proprietary Purion® process, AmnioFix™ Nerve Wrap is an allograft from amniotic tissue that is utilized for various nerve repair surgical procedures. Parker H. "Pete" Petit, Chairman and CEO, said, "AmnioFix™ Nerve Wrap is another minimally manipulated tissue offering created by our proprietary Purion® process that was developed by Surgical Biologics, a wholly-owned subsidiary of MiMedx that we acquired in  January 2011."

For use as an in vivo nerve wrap in peripheral nerve trauma, AmnioFix™ Nerve Wrap provides a protective barrier and contributes to the three phases of the natural healing process. . . inflammatory phase, proliferation phase and remodeling phase.

John Daniel, President and Founder of Surgical Biologics, stated "We are very excited to be pioneering another application for processed amniotic tissue. Ophthalmology was the industry's initial application for processed amniotic tissue. Surgical Biologics is the first and leading company specifically founded to promote the use of amniotic membrane in multiple surgical applications beyond ophthalmology. In addition to our new nerve wrap offering, Surgical Biologics has pioneered amniotic tissue uses in applications such as diabetic wound care, spinal surgery, orthopedics, burns, trauma and others."

Surgical Biologics has been supplying amniotic tissue for over five years with a stellar record of quality and safety. In addition to the MiMedx branded AmnioFix™ and EpiFix™ tissue, Surgical Biologics is also the leadi
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. MiMedx Group Announces Launch of its Paradis Vaso Shield(TM) Device
2. MiMedx Group Announces CE Mark for the HydroFix(TM) Spine Shield
3. MiMedx Group Announces Addition of Sales Director for Europe
4. MiMedx Group, Inc. Announces Release Date for Second Quarter Results
5. MiMedx Announces Agreement to Acquire Surgical Biologics
6. MiMedx Receives Additional CE Certification for Its HydroFix™ Technology
7. MiMedx Completes Acquisition of Surgical Biologics
8. MiMedx Group, Inc. Announces Release Date for First Quarter Results
9. MiMedx to Attend International Society for the Advancement of Spine Surgery Annual Meeting
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 28, 2015 P&S ... with market overview, trends, DRO analysis, market ... recent developments, competitive scenario and top competitor ... Human Insulin Market Development and Demand Forecast ... Explore more about Global Human ...
(Date:7/28/2015)... Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... on Tuesday, August 4 at 11:30 a.m. Eastern Time ... report on pipeline and business progress.  ... 877-443-5662 or access the webcast at www.isispharm.com .  ... time at the same address. ABOUT ISIS ...
(Date:7/28/2015)... 2015   DigiPath Labs , the cannabis testing ... with True North Laboratory of Ann Arbor, ... leading global supplier of diagnostic solutions for food-borne pathogens, ... rapid diagnostic test kits to screen for food-borne ... "This joint effort is expected to result in the ...
Breaking Medicine Technology:Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 2Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 3Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 4Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 5Webcast Alert: Isis Pharmaceuticals' Second Quarter 2015 Financial Results Conference Call 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2015 Financial Results Conference Call 3DigiPath Labs Partners with Romer Labs to Validate Food-Borne Pathogen and Mycotoxin Testing Solutions for Cannabis 2DigiPath Labs Partners with Romer Labs to Validate Food-Borne Pathogen and Mycotoxin Testing Solutions for Cannabis 3
... Germany, May 20 Miltenyi Biotec,announces the ... Beads. Myelin,is a specialized membrane which ensheathes ... nervous system. During preparation of single-cell,suspensions, myelin ... adult neural tissue, usually less than 5 ...
... that maintenance therapy with RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Treatment ... placebo in patients with Bipolar I Disorder. Results of ... medical meeting. Bipolar Disorder is a brain disorder ... and ability to function. It is often characterized by ...
Cached Medicine Technology:Myelin Removal Beads: Premium Efficiency for Neural Cell Separations and Antibody Stainings 2RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 2RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 3RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 4RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 5RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 6RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 7RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 8RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 9RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder 10
(Date:7/28/2015)... ... July 28, 2015 , ... BMI of Texas, which ... the duodenal switch weight loss surgery procedure. Committed to helping patients achieve ... procedures, BMI of Texas is one of the first practices in South ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... Kinetic Data announced that Schneider Electric has completed its upgrade and expansion ... a global organization with more than 170,000 employees in 134 countries supplying a ...
(Date:7/28/2015)... ... July 28, 2015 , ... A ... shipbreaking workers than they are in the general population. Surviving Mesothelioma has just ... now. , Researchers at Taiwan’s National Health Research Institutes and three Taiwanese ...
(Date:7/28/2015)... ... July 28, 2015 , ... Every summer, the public is reminded to ... when lighting fireworks in their own neighborhoods. Unfortunately, according to a recent report issued ... 2015 USA Today article " Eye Injuries Caused by Fireworks Doubled in Last 3 ...
(Date:7/28/2015)... ... July 28, 2015 , ... Most employers have been using multi-tier ... Health Plan Survey shows a significant increase in the use of 4-tier plans, which ... copays -- a trend that is expected to continue, according to UBA. , UBA’s ...
Breaking Medicine News(10 mins):Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 2Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 3Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 2Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 3Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 4Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 2Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 3Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 2Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 3Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 4Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 5
... TrinityCare Senior Living, Inc. (formerly OTCBB: JKAN) (the "Company"), ... today announced that its Board of Directors has authorized ... public entity from July 31st to December 31st. The ... re-incorporation was completed and approved on February 16, 2009 ...
... Swiss Villa Dairy Farm in Lykens, Dauphin County, ... sales of raw milk on Feb. 24, Agriculture Secretary ... has not been pasteurized. Pennsylvania farms selling raw ... milk laboratory tested due to the health risks associated ...
... N.C., Feb. 24 Though the American Medical Association ... industry funding of CME and though some big pharma ... (one even eliminating funding for CME by third-party vendors), ... medical associations and teaching hospitals is funded by the ...
... XIFIN Inc., the leading provider of revenue ... it has added two new members to its ... rapid growth.(Logo: http://www.newscom.com/cgi-bin/prnh/20081013/LAM046LOGO )Steve Zaniboni joins ... most recently served as Chief Financial Officer of ...
... As we gear up for spring, the winter ... a reminder that emergency situations can occur without warning. ... emergencies, the American Public Health Association,s (APHA) "Get Ready: ... to update their emergency preparedness kits when they change ...
... higher incidence of lung cancer compared with those with the ... this risk, according to a study in the February 24 ... Institute. , Previous studies showed that individuals with a ... cancer. Some studies have also suggested that some of the ...
Cached Medicine News:Health News:TrinityCare Senior Living, Inc. Changes Fiscal Year End to December 31st 2Health News:Educating the Market: Creating Value Through Support of Continuing Medical Education 2Health News:XIFIN Inc. Expands Its Executive Management Team 2Health News:Check Your Emergency Stocks When You Change Your Clocks, Says APHA 2Health News:Smoking behavior partially explains socioeconomic inequities in lung cancer incidence 2
Very concise book answering the question: "I've got a diagnosis, which drugs do I use?". All 15 chapters written by highly skilled US specialists...
... Guide for Nurses with Integrated Calculators, based ... is a remarkable advance in drug reference. ... Davis s Drug Guide (9th Edition) and ... based medications. This product merges many of ...
Allows health professionals to answer consumers' questions regarding safety issues concerning possible drug-herb and drug-food interactions....
... DrDrugs®: Drug Guide ... with over 760 Integrated ... most comprehensive, up-to-date and ... built in drug dosing ...
Medicine Products: